DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use

Elderly Patients Clinical Trial

— DOKTORBRAU  

Official title:

DOuble tasK Test On ergometeR - Basic Research on Acceptability and Use

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03800771
• Other study ID #: 2018-A01109-46
• Status: Completed
• Phase: N/A
• Start date: August 28, 2019
• Est. completion date: May 17, 2022

Study information

• Verified date: June 2022
• Source: University Hospital, Angers
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of the study is to show the concordance between the dual-task test achieved usually on an electronic treadmill and the dual-task test achieved with a cyclo-ergometer.

Description:

Usually, dual task tests are only achieved on electronic treadmills. Patients who are coming to perform these tests are mainly subjects with various levels of cognitive disorders and with a high risk of fall because of potential motor and cognitive disorders.

The investigator will select patients referred for double task walking tests. After the walking test, investigator will perform dual-task tests with a new bicycle device "Cycléo BRAU" which allows the patients to achieve mental tasks while cycling. The aim of using a bicycle is to limit the risk of falls compared to the treadmill or walking task. The "Cycléo BRAU" device is equiped with a video projector which projects an environment of virtual reality. It allows cycling without resistence and thus is not based on any incremental worload. The mental tasks on bicycle will be of increasing difficulty and parameters such as cycling speed will be recorded. Loss of speed regularity will be considered as an abnormal response. The task for which cycling is stopped will be recorded and compared to the results of the usual walking test.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: May 17, 2022
• Est. primary completion date: May 17, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Age = 60 years old

• Patient with a near visual acuity upper or equal to 2/10

• Patient with a score of MMSE upper than 10

• Patient able to walk on a treadmill for 15 meters on straight line without help

• Patient covered by the French health insurance

• Patient (or support person or legal representative) able to understand the protocol

• Patient (or support person or legal representative) agrees to be involve in the protocol and sign the consent form

Exclusion Criteria:

• Patient has a wash-out period for another clinical trial

• Patient with a medical contraindication to practice bicycle

• Patient with locomotor disorders preexisting, whatever the reason

• Patient needing extern help to walk like a walking frame, rollator or tricycle

• Patient with a medical or surgical disease acute from less of 3 months

• Patient with cerebrovascular accident history or any other cerebro-medullary diseases with sensorimotor consequences

• Patient with severe depression (Geriatric Depression Scale 15 items upper than 10)

• Patient with a low proficiency of French (oral or written)

Related Conditions & MeSH terms

• Elderly Patients

Intervention

Device:
• Cycléo BRAU
Practice dual-task tests.
• GAITRITE®
Routine practice dual-task tests.

Locations

Country	Name	City	State
France	CHU Angers	Angers

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Angers

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Speed	Evaluate the concordance of the speed during the tests on treadmill and on cyclo-ergometer.	12 months
Primary	Speed variability	Evaluate the concordance the speed variability during the tests on treadmill and on cyclo-ergometer.	12 months